Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 50%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow is in a strong position to continue delivering excellent performance and revenue growth, driven by its core US FFRCT business and the rapidly ramping-up emerging plaque business. The company's premium valuation is warranted considering its current momentum and projected growth, as well as its potential to expand its market by approximately $6 billion through upcoming clinical trials. We anticipate that HeartFlow's revenue will continue to be concentrated in its FFRCT business as it works to gain commercial reimbursement and adoption of its plaque product, but the potential for its plaque product to take off poses a positive outlook for margin expansion and future financial success. However, there are potential risks related to competition, reimbursement changes, and adoption of new technologies that the company should continue to address in order to maintain its strong position in the market.

Bears say

HeartFlow is experiencing positive momentum in its business operations, specifically in new account activations, ordering physicians, and Plaque utilization. Their Plaque analysis software has the potential to become their largest source of revenue with high gross margins. This could result in significant value for the company over the next few years. However, it is important to note that the broader adoption of the platform may be impacted by competitive forces, and the financials do not account for potential challenges in this area.

HeartFlow Inc (HTFL) has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 50% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 8 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of Aug 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.